157 related articles for article (PubMed ID: 23688840)
41. A series of mononuclear Co(III) complexes using tridentate N,O-donor ligands: chemical properties and cytotoxicity activity.
Souza ET; Maia PJ; Azevedo EM; Kaiser CR; Resende JA; Pinheiro CB; Heinrich TA; da Silva RS; Scarpellini M
J Inorg Biochem; 2011 Dec; 105(12):1767-73. PubMed ID: 22001498
[TBL] [Abstract][Full Text] [Related]
42. Novel dinuclear platinum(II) complexes containing mixed nitrogen-sulfur donor ligands.
Hochreuther S; Puchta R; van Eldik R
Inorg Chem; 2011 Dec; 50(24):12747-61. PubMed ID: 22085155
[TBL] [Abstract][Full Text] [Related]
43. Trans platinum complexes design: one novel water soluble oxime derivative that contains aliphatic amines in trans configuration.
Quiroga AG; Cubo L; de Blas E; Aller P; Navarro-Ranninger C
J Inorg Biochem; 2007 Jan; 101(1):104-10. PubMed ID: 17049609
[TBL] [Abstract][Full Text] [Related]
44. Ammine/amine platinum(IV) dicarboxylates: a novel class of platinum complex exhibiting selective cytotoxicity to intrinsically cisplatin-resistant human ovarian carcinoma cell lines.
Kelland LR; Murrer BA; Abel G; Giandomenico CM; Mistry P; Harrap KR
Cancer Res; 1992 Feb; 52(4):822-8. PubMed ID: 1737343
[TBL] [Abstract][Full Text] [Related]
45. Dinuclear Pt(II)-bisphosphonate complexes: a scaffold for multinuclear or different oxidation state platinum drugs.
Piccinonna S; Margiotta N; Pacifico C; Lopalco A; Denora N; Fedi S; Corsini M; Natile G
Dalton Trans; 2012 Aug; 41(32):9689-99. PubMed ID: 22782180
[TBL] [Abstract][Full Text] [Related]
46. Cytotoxic properties of a new organometallic platinum(II) complex and its gold(I) heterobimetallic derivatives.
Serratrice M; Maiore L; Zucca A; Stoccoro S; Landini I; Mini E; Massai L; Ferraro G; Merlino A; Messori L; Cinellu MA
Dalton Trans; 2016 Jan; 45(2):579-90. PubMed ID: 26609781
[TBL] [Abstract][Full Text] [Related]
47. Lipophilic Pt(II) complexes with selective efficacy against cisplatin-resistant testicular cancer cells.
Biersack B; Dietrich A; Zoldakova M; Kalinowski B; Paschke R; Schobert R; Mueller T
J Inorg Biochem; 2011 Dec; 105(12):1630-7. PubMed ID: 22071088
[TBL] [Abstract][Full Text] [Related]
48. Synthesis, characterization and cytotoxicity of iodo-bridged binuclear platinum(II) complexes.
Zhang J; Li L; Ji X; Sun J; Wang L; Zhang Y
Eur J Med Chem; 2010 Jun; 45(6):2634-7. PubMed ID: 20153562
[TBL] [Abstract][Full Text] [Related]
49. Studies on the activity of two Trans-planaramine platinum(II) complexes coded as DH4 and DH5 in human ovarian tumour models.
Deqnah N; Yu JQ; Beale P; Huq F
Anticancer Res; 2012 Dec; 32(12):5331-6. PubMed ID: 23225434
[TBL] [Abstract][Full Text] [Related]
50. Synthesis, characterization and cytotoxicity evaluation of some new platinum(II) complexes of tetrazolo[1,5-a]quinolines.
Bekhit AA; El-Sayed OA; Al-Allaf TA; Aboul-Enein HY; Kunhi M; Pulicat SM; Al-Hussain K; Al-Khodairy F; Arif J
Eur J Med Chem; 2004 Jun; 39(6):499-505. PubMed ID: 15183908
[TBL] [Abstract][Full Text] [Related]
51. Second- and higher-order structural changes of DNA induced by antitumor-active tetrazolato-bridged dinuclear platinum(II) complexes with different types of 5-substituent.
Uemura M; Yoshikawa Y; Yoshikawa K; Sato T; Mino Y; Chikuma M; Komeda S
J Inorg Biochem; 2013 Oct; 127():169-74. PubMed ID: 23725767
[TBL] [Abstract][Full Text] [Related]
52. Synthesis, crystal structure, DNA-binding and cytotoxicity in vitro of novel cis-Pt(II) and trans-Pd(II) pyridine carboxamide complexes.
Shi CY; Gao EJ; Ma S; Wang ML; Liu QT
Bioorg Med Chem Lett; 2010 Dec; 20(24):7250-4. PubMed ID: 21071219
[TBL] [Abstract][Full Text] [Related]
53. Mechanistic studies on the reactions of platinum(II) complexes with nitrogen- and sulfur-donor biomolecules.
Bugarčić ŽD; Bogojeski J; Petrović B; Hochreuther S; van Eldik R
Dalton Trans; 2012 Oct; 41(40):12329-45. PubMed ID: 22890549
[TBL] [Abstract][Full Text] [Related]
54. Cationic arene ruthenium(II) complexes with chelating P-functionalized alkyl phenyl sulfide and sulfoxide ligands as potent anticancer agents.
Ludwig G; Kaluđerović GN; Rüffer T; Bette M; Korb M; Block M; Paschke R; Lang H; Steinborn D
Dalton Trans; 2013 Mar; 42(11):3771-4. PubMed ID: 23340605
[TBL] [Abstract][Full Text] [Related]
55. Evaluation of in vitro cytotoxicity and hepatotoxicity of platinum(II) and palladium(II) oxalato complexes with adenine derivatives as carrier ligands.
Vrzal R; Starha P; Dvorák Z; Trávnícek Z
J Inorg Biochem; 2010 Oct; 104(10):1130-2. PubMed ID: 20673688
[TBL] [Abstract][Full Text] [Related]
56. Tetravalent platinum complexes with ammine/amine carrier ligand configuration: circumvention of platinum resistance in vivo.
Siddik ZH; Thai G; Yoshida M; Zhang YP; Khokhar AR
Anticancer Drug Des; 1994 Dec; 9(6):495-509. PubMed ID: 7880375
[TBL] [Abstract][Full Text] [Related]
57. High antitumor activity of 5,7-dihalo-8-quinolinolato cerium complexes.
Chen ZF; Wei JH; Liu YC; Liu M; Gu YQ; Huang KB; Wang M; Liang H
Eur J Med Chem; 2013 Oct; 68():454-62. PubMed ID: 23995094
[TBL] [Abstract][Full Text] [Related]
58. Fluorescent analogues of quinoline reveal amine ligand loss from cis and trans platinum(II) complexes in cancer cells.
New EJ; Roche C; Madawala R; Zhang JZ; Hambley TW
J Inorg Biochem; 2009 Aug; 103(8):1120-5. PubMed ID: 19564043
[TBL] [Abstract][Full Text] [Related]
59. Solid-phase synthesis and pharmacological evaluation of novel nucleoside-tethered dinuclear platinum(II) complexes.
D'Errico S; Oliviero G; Piccialli V; Amato J; Borbone N; D'Atri V; D'Alessio F; Di Noto R; Ruffo F; Salvatore F; Piccialli G
Bioorg Med Chem Lett; 2011 Oct; 21(19):5835-8. PubMed ID: 21855340
[TBL] [Abstract][Full Text] [Related]
60. Design and biological evaluation of new platinum(II) complexes bearing ligands with DNA-targeting ability.
Herrera JM; Mendes F; Gama S; Santos I; Navarro Ranninger C; Cabrera S; Quiroga AG
Inorg Chem; 2014 Dec; 53(23):12627-34. PubMed ID: 25402634
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
